ADRX ADARx Pharmaceuticals, Inc.
$17.68▲ +0.28%
Healthcare
Other
Volume 1.07M
Avg Volume (10D) 449.9K
Key Metrics & Fundamentals
Market Cap
$1.89B
P/E Ratio
–
Div Yield
0.00%
52W Range
16.61 - 23.21
% vs 50 MA
–%
% vs 200 MA
–%
RSI-14
38.9
Free Cash Flow
-$27.56M
Gross Rev
$746,000
Gross Profit
$746,000
EBITDA
-$29.16M
COGS
–
Operating Exp
$30.64M
Operating Income
-$29.89M
EBIT
-$29.89M
Pretax Income
-$25.76M
Net Income
-$25.76M
Price & Volume History
Loading chart…
Recent News
ADARx Pharmaceuticals Announces the Closing of Full Exercise of Underwriters’ Option to Purchase Additional Shares Granted in Its Initial Public Offering
GlobeNewswire · Oct 1, 2026 4:15 PM ET
ADARx Pharmaceuticals (ADRX) Moved Higher, But What Is Drawing Attention?
Simply Wall St. · Sep 27, 2026 11:10 PM ET
ADARx Pharmaceuticals Announces Pricing of Upsized $446.3 Million Initial Public Offering
GlobeNewswire · Sep 24, 2026 7:33 PM ET
Financial Overview - Income Statement
Quarterly
Jun 2026
See ADRX's money flow as a full page
Social Sentiment
No Reddit posts found for ADRX.
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.